Board approves manufacturing expansion, up to Rs 75 cr loan

Capex above 10% of net worthCapex & Operations View source PDF Explain this filing

ANUHPHR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+5.7%Reaction day

₹82.45

prior close

₹83.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.7%+4.9% vs market

Pharmaceuticals peers, median of 172sector-0.0%+5.7% vs sector

On the reaction day the stock moved 4.9 pts more than Nifty Microcap 250 and 5.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

+0.4

15m

+0.5

30m

-0.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+5.7+0.7+4.9-0.0+5.7

Next day

+1.3-1.0+2.3-0.8+2.2

+0.5-0.3+0.8-0.6+1.1

-0.2-1.9+1.7-1.9+1.7

-3.3-4.5+1.2-3.5+0.3

-5.1-5.5+0.3-4.4-0.7

-7.0-7.3+0.3-4.3-2.7

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Anuh Pharma's board approved investing in new manufacturing assets to expand its production capacity. The board also cleared a proposal to raise a loan of up to Rs 75 crores to fund the purchase of these assets. Loan terms and applicable approvals are yet to be finalised. The move signals the company's plans to scale up its manufacturing footprint.

Likely market impact

Growth-oriented capex; Rs 75 cr debt may pressure finances short term but could drive future revenue if expansion is executed well.